Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

CGRP receptor antagonist MK-8825 attenuates cortical spreading depression induced pain behavior

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Sleep in cluster headache revisited: Results from a controlled actigraphic study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Migraine is associated with high brain 5-HT levels as indexed by 5-HT4 receptor binding

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Sildenafil and calcitonin gene-related peptide dilate intradural arteries: A 3T MR angiography study in healthy volunteers

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Board Walk - July 2019

    Publikation: Bidrag til tidsskriftLederForskningpeer review

  1. Does inflammation have a role in migraine?

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. The changing faces of migraine

    Publikation: Bidrag til tidsskriftLederForskningpeer review

  3. Board Walk - July 2019

    Publikation: Bidrag til tidsskriftLederForskningpeer review

  • Aslı Filiz
  • Nermin Tepe
  • Sajedeh Eftekhari
  • H Evren Boran
  • Ergin Dilekoz
  • Lars Edvinsson
  • Hayrunnisa Bolay
Vis graf over relationer

Background and objective The present study aimed to investigate the effects of selective calcitonin gene related peptide (CGRP) receptor antagonist (MK-8825) on cortical spreading depression (CSD) induced pain behavior and anxiety in freely-moving rats, and neuronal activation in the correlated anatomical regions. Methods CSD was induced while keeping all meningeal layers and BBB intact and MK-8825 was administered in two different doses. Regional cerebral blood flow (rCBF), arterial pressure and DC shift were recorded. Behavioral studies were conducted in freely-moving rats. Spontaneous behavior, mechanical allodynia, ultrasonic vocalization, and anxiety were evaluated. Immunohistochemistry of c-fos, CGRP, calcitonin receptor like-receptor (CLR) and receptor activity modifying protein 1 (RAMP1) were studied. Results MK-8825 did not block DC shifts in the cerebral cortex and accompanied hemodynamic response. CSD significantly induced freezing and grooming behavior in freely-moving rats. MK-8825 reversed increased episodes of freezing, grooming, wet dog shake and head shake behavior. MK-8825 increased CSD-induced reductions in von Frey thresholds, but did not change elevated plus maze results. MK-8825 blocked c-fos induction by CSD in the brainstem trigeminal nucleus caudalis (TNC) and reticular nucleus of thalamus (TRN) but not in the amygdala. Immunofluorescence analysis showed no co-localization of CGRP, CLR or RAMP1 with c-fos positive cells. Conclusion CGRP receptor antagonist MK-8825 dose dependently attenuated CSD-induced trigeminal nerve mediated pain response without altering CSD waves and accompanied rCBF response. While blocking TNC activation, MK-8825 did not exert any effect on amygdala and anxiety behavior. CGRP receptor antagonists may also modulate thalamo-cortical gating.

OriginalsprogEngelsk
TidsskriftCephalalgia : an international journal of headache
Vol/bind39
Udgave nummer3
Sider (fra-til)354-365
Antal sider12
ISSN0333-1024
DOI
StatusUdgivet - 1 mar. 2019
Eksternt udgivetJa

ID: 52342274